Related Experiment Video
Updated: Jul 23, 2025

07:15
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
Published on: July 28, 2020
9.6K
Recurrent cervical adenofibroma progressing to adenosarcoma: a rare case report.
Li Chen1, Yugang Chi2, Yanlin Chen2
1Women and Children's Hospital of Chongqing Medical University/Chongqing Health Centre for Women and Children, Chongqing, China, China. appleli1023@163.com.
Ginekologia Polska
|July 12, 2023
Summary
Cervical adenofibroma can recur and progress to adenosarcoma, a rare malignancy. Prompt diagnosis through combined histological and immunohistochemical investigation is crucial for recurrent cervical masses.
Area of Science:
- Gynecologic Oncology
- Pathology
- Oncologic Imaging
Background:
- Cervical adenofibroma, a rare mixed mesodermal tumor, can manifest as recurrent cervical polyps.
- Progression to cervical adenosarcoma is uncommon but documented.
- Recurrent polypoidal masses necessitate thorough differential diagnosis.
Purpose of the Study:
- To report a case of cervical adenofibroma progressing to adenosarcoma.
- To emphasize the importance of differential diagnosis in recurrent cervical masses.
- To highlight the diagnostic challenges of cervical adenofibroma.
Main Methods:
- Case report of a patient with a 10-year history of recurrent cervical polypoidal mass.
- Diagnostic imaging included ultrasound and magnetic resonance imaging (MRI).
- Surgical pathology and immunohistochemistry confirmed cervical adenosarcoma after wide local excision via hysteroscopy.
Main Results:
- The patient presented with the eighth recurrence of a cervical polypoidal mass.
- Histopathological and immunohistochemical analysis confirmed the diagnosis of cervical adenosarcoma.
- Despite conservative management, the potential for recurrence and progression was noted.
Conclusions:
- Diagnosing cervical adenofibroma and differentiating it from adenosarcoma is challenging.
- Adenosarcoma must be excluded in cases of recurrent cervical polypoidal masses.
- A combined histological and immunohistochemical approach is essential for accurate diagnosis.
Related Concept Videos
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K

